BioUtah has opened Early Bird registration for the 2025 Utah Life Sciences Summit presented by Mayer Brown, offering reduced pricing until October 17 for the November 12 event at the Hilton Salt Lake City Center. The summit typically attracts over 500 registrants and serves as a crucial gathering point for life sciences leaders, experts, policymakers, and professionals to discuss industry dynamics, regulatory landscapes, market trends, and innovation strategies.
The importance of this event extends beyond networking opportunities, as Utah has emerged as one of the nation's fastest-growing life sciences hubs, contributing $22.6 billion to Utah's GDP and supporting approximately 180,000 jobs. This economic impact underscores why the summit's discussions about regulatory challenges and market access directly affect both the state's economy and national healthcare innovation. Registration details and preliminary agenda information are available at https://bioutah.org/summit-registration and https://bioutah.org/summit-agenda.
This year's keynote speaker lineup includes significant federal regulatory figures whose decisions directly impact life sciences companies nationwide. Melissa Holyoak, Commissioner of the Federal Trade Commission, brings expertise in healthcare market competition and mergers at a time when industry consolidation remains a critical concern. Michelle Tarver, MD, PhD, Director of FDA's Center for Devices and Radiological Health, will conduct a virtual FDA Town Hall addressing the agency's policy priorities and regulatory initiatives that affect medical device approval processes.
Another notable speaker, Peter Marks, MD, former head of the FDA's Center for Biologics Evaluation and Research, oversaw rapid expansion in FDA-approved cell and gene therapies and played a key role in establishing Operation Warp Speed. His insights into accelerated regulatory pathways for breakthrough treatments could influence how companies approach developing next-generation therapies. Carter Dredge, Executive Director of the Intermountain Health Institute, rounds out the speaker roster as a global healthcare thought leader focused on creating novel solutions to complex healthcare problems.
The summit's structured networking program and specialized tracks covering workforce development, market access, regulatory compliance, and legal issues provide practical value for professionals across medical device manufacturing, diagnostics, and biopharmaceutical sectors. As Kelvyn Cullimore, president and CEO of BioUtah, noted, the event brings together groundbreaking startups and established industry leaders for discovery, collaboration, and inspiration that drives healthcare advancement forward.
